Clinical Trials in Nashville

Showing 17841-17860 of 20,298 trials

A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors

NCT00708006

The purpose of this study is to evaluate the safety and tolerability of HGS1029 in subjects with advanced solid tumors and to determine a phase 2 dose.

Advanced Solid Tumors

Human Genome Sciences Inc.66 participantsStarted May 2008

Stanford, California, United States • Aurora, Colorado, United States • Nashville, Tennessee, United States

COMPLETEDPhase 2< 1 mile

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

NCT00282022

RATIONALE: Drugs used in chemotherapy, such as VNP40101M, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well VNP40101M works in treating patients with recurrent or refractory locally advanced or metastatic small cell lung cancer.

Lung Cancer

Vion Pharmaceuticals87 participantsStarted Sep 2005

Los Angeles, California, United States • New Haven, Connecticut, United States • West Haven, Connecticut, United States +6 more locations

A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Find Trials by Condition in Nashville

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma

Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

3-AP in Treating Patients With Advanced Prostate Cancer

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer